Clinical Trial Update: A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rituximab plus chemotherapy for follicular lymphoma in elderly patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University of Liverpool | Conditions: Follicular Lymphoma | Phase 3 | Status: COMPLETED